Meanwhile, high expression of HAVCR2 was significantly correlated with the poor prognosis of ovarian cancer (39), colon cancer (40), bladder urothelial carcinoma (41), and gastric cancer (42). This evidence concerns the gene HAVCR2 and colonic neoplasm.